期刊文献+

PLK1基因沉默对K562/A02细胞周期、增殖和耐药性的影响 被引量:5

Effect of PLK1 Gene Silence on Cell Cycle, Proliferation and Drug Resistance in K562/A02 Cells
在线阅读 下载PDF
导出
摘要 为了探讨小干扰RNA(siRNA)对K562/A02细胞Polo样激酶1(PLK1)基因的抑制作用及其对细胞周期、细胞增殖和耐药性的影响,将构建的针对PLK1mRNA的siRNA真核质粒,导入K562/A02细胞,用RT-PCR和Western-blot方法分析PLK1基因在转染前后的表达差异;台盼蓝拒染试验检测细胞存活率;流式细胞术(FACS)检测细胞周期和细胞内阿霉素(ADM)的积累量;MTT试验检测细胞对ADM的药物敏感性。结果显示,与对照组相比,转染24和48小时后,siRNA-PLK1质粒转染组的PLK1mRNA下降(34.7±2.1)%和(56.6±1.5)%,蛋白水平下降(49.9±3.2)%和(62.1±1.7)%;转染24和48小时后,细胞存活率下降了30%和59%;转染48小时后,G2/M期细胞比例提高了2.77倍,同时细胞内ADM积累量显著提高;对ADM药物敏感性的相对率为73.8%。结论:PLK1基因沉默能有效抑制K562/A02细胞生长,使细胞周期停滞在G2/M期,同时使得细胞内ADM积累量提高,对ADM敏感性增强。 The study was purposed to investigate the effect of small interference RNA (siRNA) targeting Polo-like kinase 1 ( PLK1 ) gene on cell cycle progression, proliferation and drug resistance in K562/A02 cells, siRNA plasmid vector specifically targeting PLK1 gene with enhanced green fluorescence protein (EGFP) was transfected into K562/ A02 cells. Expressions of PLK1 mRNA and protein were assayed by RT-PCR and Western-blot; cell proliferation was evaluated by direct cell counting after trypan blue staining. Cell cycle and intracellular adriamycin(ADM) accumulation was determined by flow cytometry; 50% inhibition concentration ( IC50 ) of ADM on K562/A02 cells was determined by MTT method. The results showed that, as compared with control cells, siRNA plasmid reduced PLK1 mRNA expression by ( 34. 7 ± 2. 1 ) % for 24 hours and by ( 56. 6 ± 1. 5 ) % for 48 hours, PLK1 protein significantly decreased simultaneously by (49.9 ± 3.2 ) % and by ( 62.1 ± 1.7 ) %. After being transfected for 24 and 48 hours, the rate of survival cells decreased by 30% and 59% respectively. Forty-eight hours after transfection, the ratio of K562/A02 cells at G2/M increased by 2.77-fold, at the same time, intracellular ADM accumulation increased and the relative efficiency of K562/A02 cells to ADM was 73.8%. It is concluded that PLK1 gene silence can inhibit K562/A02 cell proliferation, induce cell cycle arrest at G2/M, and increase intracellular ADM accumulation, so that enhance cell sensitivity to ADM.
出处 《中国实验血液学杂志》 CAS CSCD 2006年第2期241-246,共6页 Journal of Experimental Hematology
关键词 PLK1基因沉默 SIRNA质粒 K562细胞/A02细胞 细胞周期 耐药性 PLK1 gene silence siRNA plasmid K562 cell/A02 cell cell cycle drug resistance
  • 相关文献

参考文献10

  • 1Lowery DM,Lim D,Yaffe MB.Structure and function of Polo-like kinases.Oncogene,2005; 24:248-259.
  • 2Eckerdt F,Yuan J,Strebhardt K.Polo-like kinases and oncogenesis.Oncogene,2005; 24:267 -276.
  • 3Liu X,Erikson RL.Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells.Proc Natl Acad Sci USA,2003; 100:5789-57794.
  • 4何一心,杨少光.多药耐药性细胞的鉴别和分离[J].中华血液学杂志,1992,13(4):173-175. 被引量:16
  • 5Fisher,R,Ferris DK.The functions of Polo-like kinases and their relevance to human disease.Curr Med Chem,2002; 2:125 -134.
  • 6Takai N,Hamanaka R,Yoshimatsu J,et al.Polo-like kinases (Plks) and cancer.Oncogene,2005; 24:287-291.
  • 7Wolf G,Elez R,Doermer A,et al.Prognostic significance of pololike kinase (PLK) expression in non-small cell lung cancer.Oncogene,1997; 14:543 -549.
  • 8Chambers TC,McAvoy EM,Jacobs JW,et al.Protein Kinase C phosphorylates P-glycoprotein in multidrug resistance human KB carcinoma cells.J Biol Chem,1990; 265:7679 -7686.
  • 9Yokoyama G,Fujii T,Tayama K,et al.PKCdelta and MAPK mediate G(1) arrest induced by PMA in SKBR-3 breast cancer cells.Biochem Biophys Res Commun,2005; 327:720-726.
  • 10谭耀红,杨纯正,赵春华,齐静,彭晖,王建祥,周圆,肖瑛,兰岚.NF-H基因参与K562/A02细胞多药耐药机制形成的研究[J].中华肿瘤杂志,2004,26(6):328-332. 被引量:5

二级参考文献17

  • 1Lieberburg I, Spinner N, Snyder S, et al. Cloning of a cDNA encoding the rat high molecular weight neurofilament peptide (NF-H): developmental and tissue expression in the rat, and mapping of its human homologue to chromosomes 1 and 22. Proc Natl Acad Sci
  • 2Davidoff MS, Middendorff R, Pusch E, et al. Sertoli and Leydig cells of the human testis express neurofilament triplet proteins. Histochem Cell Biol, 1999, 111: 173-187.
  • 3Mattei MG, Dautigny A, Pham-Dinh D, et al. The gene encoding the large human neurofilament submit (NF-H) maps to the q121-131 region on human chromosome22. Hum Genet, 1998, 80: 293-295.
  • 4Schleicher RL, Hunter SB, Varma VA, et al. Neurofilament heavy chain-like messenger RNA and protein are present in benign prostate and down-regulated in prostatic carcinoma. Cancer Res, 1997, 57: 3532-3536.
  • 5Yang CZ, Luan FJ, Xiong DS, et al. Multidrug resistance in leukemia cell line K562/A02 induced by doxorubicin. Zhongguo Yao Li Xue Bao, 1995, 16: 333-337.
  • 6Davidoff MS, Middendorff R, Pusch W, et al. Sertoli and Leydig cells of the human testis express neuroilament triplet protein. Histochem Cell Biol, 1999, 111: 173-187.
  • 7Cucco C, Calabretta B. In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides. Cancer Res, 1996, 56: 4332-4337.
  • 8Higgins CF. The multidrug resistance P-glycoprotein. Curr Opin Cell Biol, 1993, 5: 684-687.
  • 9Grant CE, Valdimarsson G, Hipfner DR, et al. Overexpression of multidrug resistance-associated protein(MRP) increases resistance to natural product drugs. Cancer Res, 1994, 54: 357-361.
  • 10Izquierdo MA, Scheffer GL, Flens MJ, et al. Major vault protein LRP-related multidrug resistance. Eur J Cancer, 1996, 32A: 979-984.

共引文献19

同被引文献77

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部